Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 ILa | +3.57% | +11.54% | +11.54% |
May. 12 | Transcript : Can-Fite BioPharma Ltd. - Special Call | |
May. 09 | Can-Fite BioPharma Ltd. Announces FDA Grants IND Clearance for Namodenoson to Treat MASH Patients in a Phase IIb Study | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.54% | 11.41M | |
-1.62% | 89.22B | |
+2.24% | 40.49B | |
-12.97% | 32.79B | |
+63.75% | 26.23B | |
-20.71% | 14.52B | |
-7.31% | 13.09B | |
-12.64% | 11.5B | |
-42.60% | 11.6B | |
+5.39% | 8.82B |
- Stock Market
- Equities
- CANF Stock
- News Can-Fite BioPharma Ltd.
- Transcript : Can-Fite BioPharma Ltd. - Special Call